Targetable mutations are treated using targeted therapies, which are drugs designed to specifically inhibit the activity of the mutated proteins. These therapies often have fewer side effects compared to conventional chemotherapy as they aim to target only cancer cells while sparing normal cells. Examples of targeted therapies include tyrosine kinase inhibitors (TKIs), monoclonal antibodies, and small molecule inhibitors.
